Abstract:Peroxiredoxin-I is a protein encoded by the Peroxiredoxin I gene, which highly expressed in many tumor tissues, such as lung cancer, breast cancer, rectal cancer, stomach cancer. Peroxiredoxin-I has a proliferative effect and plays a role in cancer development, recurrence or progression. The mAb 109 antibody can specific binding to Peroxiredoxin-I protein. We recently reported the synthesis Tc-99m-labeled mAb109 for Single-photon emission computed tomography (SPECT) imaging. Those studies have showed that Tc-99m-mAb 109 still preserved its biological functions and specifically binding to the target tumors. The aim of this research was to develop new radionuclide labeled mAb109 antibody for prolonged tumor targeted molecular imaging. In this paper, the precursor compound 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane1,4,7,10-tetraacetic acid-mAb 109 (DOTA-mAb109) was synthesized for potential radioactive imaging agents. Then, a radioisotope indium-111 (t(1/2)= 67.3 h) was labeling to DOTA-mAb109 for further radio-biological evaluation. The DOTA is chelated to the In-111(3+) center through four nitrogens and four carboxylate oxygens, resulting in an eight-coordinate complex. The labeling efficiency of In-111-DOTA-mAb109 was tested by Radio-TLC/HPLC. The radiolabeling yield was over 96%, the radio chemical purity was over 99% by PD-10 column purification. The in vitro stability tests were presented in 5% Human serum albumin (HSA) for 72 h at 25 degrees C Less than 5% In-111 dissociation was detected by Radio-HPLC. In-111-DOTA-mAb109 shows excellent radiochemical property. Nano-SPECT imaging of pancreatic carcinoma-1 tumor-bearing nude mice revealed that tumor uptake of In-111-DOTA-mAb109 got a gradual accumulation from 24 h, 48 h to 72 h after post-injection of 18.5 MBq radiolabeled antibody. The cardiac area was clearly seen up to 48 h post injection, reflecting a long blood circulation time for In-111-DOTA-mAb109. Uptake in the tumor was clearly visualized by emission computed tomography. These results suggest that the In-111-DOTA-mAb109 molecular probe is a promising tracer for tumor diagnosis.

Synthesis and biodistribution of a novel 99m Tc-DMSA-metronidazole ester as a potential tumor hypoxia imaging agent

Synthesis and Biological Evaluation of Novel 99Mtcn-Labeled Bisnitroimidazole Complexes Containing Monoamine-Monoamide Dithiol As Potential Tumor Hypoxia Markers

Preparation and bioevaluation of a novel 99m Tc-labelled propylene amine oxime (PnAO) containing two 4-methyl-2-nitroimidazole groups as a promising tumor hypoxia imaging agent

Synthesis and Biodistribution of A New 99Mtc-Oxo Complex with Deoxyglucose Dithiocarbamate for Tumor Imaging

Kit formulation for preparation and biological evaluation of a novel 99m Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia

Preparation and Bioevaluation of a Novel 99Mtc-Labelled Propylene Amine Oxime (pnao) Containing Two 4-Methyl-2-nitroimidazole Groups As a Promising Tumor Hypoxia Imaging Agent

Synthesis And Biodistribution Of Novel Tc-99m Labeled 4-Nitroimidazole Dithiocarbamate Complexes As Potential Agents To Target Tumor Hypoxia

Synthesis, Radiolabeling and in Vivo Biological Evaluation of 99Mtc-Labeled MAG3-based Bisnitroimidazole Complexes As Tumor Hypoxia Markers

Synthesis and preliminary biological evaluation of the 99mTc labeled nitrobenzoimidazole and nitrotriazole as tumor hypoxia markers.

Synthesis and evaluation of a novel 99mTcN(PNP)-complex with metronidazole isocyanide ligand as a marker for tumor hypoxia

Preliminary Studies of a Novel Cyclopentadienyl Tricarbonyl Technetium-99M Fatty Acid Derivative for Myocardical Imaging.

Preparation and Biological Evaluation of 99Mtc-N4ipa for Single Photon Emission Computerized Tomography Imaging of Hypoxia in Mouse Tumor

Synthesis and Biodistribution of the 99m Tc Nitrido Complex with 2-(4-nitro-1h-imidazolyl)ethyl Dithiocarbamate (NIET)

Synthesis and Biodistribution of 99Tcm-MAG2-Ade as A Tumor Imaging Agent

Synthesis and Radiolabeling of (64)Cu-Labeled 2-Nitroimidazole Derivative (64)Cu-Bms2p2 for Hypoxia Imaging.

Synthesis,Radiolabeling and Biodistribution of ~(99)Tc~m-Bnao Ethylene Glycol Monoethyl Ether Derivate

Synthesis and Preliminary Evaluation of a Novel 18F-Labeled 2-Nitroimidazole Derivative for Hypoxia Imaging

Synthesis and Evaluation Of111in-Dota-mab109 Monoclonal Antibody for Potential SPECT Molecular Imaging

Synthesis, characterization and density functional theory of 64 Cu based complex for hypoxia imaging

Novel 99mTc-Labeled Mannose Derivative as a Highly Promising Single Photon Emission Computed Tomography Probe for Tumor Imaging

Synthesis and in Vitro Evaluation of Three (99M)tc-Labeled Hydroxamamide-Based Ligands As Markers for Hypoxic Cells